Skip to main content

FABHALTA coverage

FABHALTA coverage information*

  • 84% of initiated prior authorizations (PAs) were approved for adults with PNH who were prescribed FABHALTA1

  • Adults with PNH who were prescribed FABHALTA had their PA approved in less than 13 days on average1

  • Adults with PNH who were prescribed FABHALTA started treatment 20 days from time of prescription on average1

*Coverage information is subject to change by the relevant plan and is based on data up to September 2024. The information provided in this communication is not a guarantee of coverage or payment (partial or full). Actual coverage and reimbursement decisions are made by individual payers following the receipt of claims.

Learn about Novartis Patient Support

See how adult patients take FABHALTA

Hear medical experts discuss FABHALTA

Definitions
PNH, paroxysmal nocturnal hemoglobinuria.

Reference
1. Data on file. FABHALTA PNH MMIT Coverage. Novartis Pharmaceuticals Corp; 2024.